Brought to you by 
Pfizer licenses generics portfolio from Aurobindo Pharma
22 May 2009
Executive Summary
Indian generics company Aurobindo Pharma has licensed Pfizer rights to market and commercialize 39 oral generics in the US, with 20 of those to be sold in Europe (11 in France). In addition, Pfizer gets rights to sell 12 sterile injectable antibiotics (penicillin and cephalosporin) in the US and Europe.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pfizer licenses generics portfolio from Aurobindo Pharma
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice